Cargando…
GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease
BACKGROUND: Growth differentiation factor-15 (GDF-15), a cytokine associated with cardiovascular mortality, increases during chronic obstructive pulmonary disease (COPD) exacerbations, but any role in stable COPD is unknown. We tested associations between GDF-15 and subclinical coronary atherosclero...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331711/ https://www.ncbi.nlm.nih.gov/pubmed/28245821 http://dx.doi.org/10.1186/s12931-017-0521-1 |
_version_ | 1782511432626077696 |
---|---|
author | Martinez, Carlos H. Freeman, Christine M. Nelson, Joshua D. Murray, Susan Wang, Xin Budoff, Matthew J. Dransfield, Mark T. Hokanson, John E. Kazerooni, Ella A. Kinney, Gregory L. Regan, Elizabeth A. Wells, J. Michael Martinez, Fernando J. Han, MeiLan K. Curtis, Jeffrey L. |
author_facet | Martinez, Carlos H. Freeman, Christine M. Nelson, Joshua D. Murray, Susan Wang, Xin Budoff, Matthew J. Dransfield, Mark T. Hokanson, John E. Kazerooni, Ella A. Kinney, Gregory L. Regan, Elizabeth A. Wells, J. Michael Martinez, Fernando J. Han, MeiLan K. Curtis, Jeffrey L. |
author_sort | Martinez, Carlos H. |
collection | PubMed |
description | BACKGROUND: Growth differentiation factor-15 (GDF-15), a cytokine associated with cardiovascular mortality, increases during chronic obstructive pulmonary disease (COPD) exacerbations, but any role in stable COPD is unknown. We tested associations between GDF-15 and subclinical coronary atherosclerosis, assessed by coronary artery calcium (CAC) score, in COPD subjects free of clinical cardiovascular disease (CVD). METHODS: Cross-sectional analysis of COPD participants (GOLD stages 2–4) in the COPDGene cohort without CVD at enrollment, using baseline CAC (from non-EKG-gated chest computed tomography) and plasma GDF-15 (by custom ELISA). We used multinomial logistic modeling of GDF-15 associations with CAC, adjusting for demographics, baseline risk (calculated using the HEART: Personal Heart Early Assessment Risk Tool (Budoff et al. 114:1761-1791, 2006) score), smoking history, measures of airflow obstruction, emphysema and airway disease severity. RESULTS: Among 694 participants with COPD (47% women, mean age 63.6 years) mean GDF-15 was 1,304 pg/mL, and mean CAC score was 198. Relative to the lower GDF-15 tertile, higher tertiles showed bivariate association with increasing CAC score (mid tertile odds ratio [OR] 1.80, 95% confidence interval [CI] 1.29, 2.51; higher tertile OR 2.86, CI 2.04, 4.02). This association was maintained after additionally adjusting for baseline CVD risk, for co-morbidities and descriptors of COPD severity and impact, markers of cardiac stress (N-terminal pro–B-type natriuretic peptide, troponin T) and of inflammation (Interleukin-6), and in subgroup analysis excluding men, diabetics, current smokers or those with limited ambulation. CONCLUSIONS: In ever-smokers with COPD free of clinical CVD, GDF-15 contributes independently to subclinical coronary atherosclerosis. TRIAL REGISTRATION: ClinicalTrials.gov, NCT00608764. Registered 28 January 2008. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12931-017-0521-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5331711 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-53317112017-03-06 GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease Martinez, Carlos H. Freeman, Christine M. Nelson, Joshua D. Murray, Susan Wang, Xin Budoff, Matthew J. Dransfield, Mark T. Hokanson, John E. Kazerooni, Ella A. Kinney, Gregory L. Regan, Elizabeth A. Wells, J. Michael Martinez, Fernando J. Han, MeiLan K. Curtis, Jeffrey L. Respir Res Research BACKGROUND: Growth differentiation factor-15 (GDF-15), a cytokine associated with cardiovascular mortality, increases during chronic obstructive pulmonary disease (COPD) exacerbations, but any role in stable COPD is unknown. We tested associations between GDF-15 and subclinical coronary atherosclerosis, assessed by coronary artery calcium (CAC) score, in COPD subjects free of clinical cardiovascular disease (CVD). METHODS: Cross-sectional analysis of COPD participants (GOLD stages 2–4) in the COPDGene cohort without CVD at enrollment, using baseline CAC (from non-EKG-gated chest computed tomography) and plasma GDF-15 (by custom ELISA). We used multinomial logistic modeling of GDF-15 associations with CAC, adjusting for demographics, baseline risk (calculated using the HEART: Personal Heart Early Assessment Risk Tool (Budoff et al. 114:1761-1791, 2006) score), smoking history, measures of airflow obstruction, emphysema and airway disease severity. RESULTS: Among 694 participants with COPD (47% women, mean age 63.6 years) mean GDF-15 was 1,304 pg/mL, and mean CAC score was 198. Relative to the lower GDF-15 tertile, higher tertiles showed bivariate association with increasing CAC score (mid tertile odds ratio [OR] 1.80, 95% confidence interval [CI] 1.29, 2.51; higher tertile OR 2.86, CI 2.04, 4.02). This association was maintained after additionally adjusting for baseline CVD risk, for co-morbidities and descriptors of COPD severity and impact, markers of cardiac stress (N-terminal pro–B-type natriuretic peptide, troponin T) and of inflammation (Interleukin-6), and in subgroup analysis excluding men, diabetics, current smokers or those with limited ambulation. CONCLUSIONS: In ever-smokers with COPD free of clinical CVD, GDF-15 contributes independently to subclinical coronary atherosclerosis. TRIAL REGISTRATION: ClinicalTrials.gov, NCT00608764. Registered 28 January 2008. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12931-017-0521-1) contains supplementary material, which is available to authorized users. BioMed Central 2017-02-28 2017 /pmc/articles/PMC5331711/ /pubmed/28245821 http://dx.doi.org/10.1186/s12931-017-0521-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Martinez, Carlos H. Freeman, Christine M. Nelson, Joshua D. Murray, Susan Wang, Xin Budoff, Matthew J. Dransfield, Mark T. Hokanson, John E. Kazerooni, Ella A. Kinney, Gregory L. Regan, Elizabeth A. Wells, J. Michael Martinez, Fernando J. Han, MeiLan K. Curtis, Jeffrey L. GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease |
title | GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease |
title_full | GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease |
title_fullStr | GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease |
title_full_unstemmed | GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease |
title_short | GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease |
title_sort | gdf-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331711/ https://www.ncbi.nlm.nih.gov/pubmed/28245821 http://dx.doi.org/10.1186/s12931-017-0521-1 |
work_keys_str_mv | AT martinezcarlosh gdf15plasmalevelsinchronicobstructivepulmonarydiseaseareassociatedwithsubclinicalcoronaryarterydisease AT freemanchristinem gdf15plasmalevelsinchronicobstructivepulmonarydiseaseareassociatedwithsubclinicalcoronaryarterydisease AT nelsonjoshuad gdf15plasmalevelsinchronicobstructivepulmonarydiseaseareassociatedwithsubclinicalcoronaryarterydisease AT murraysusan gdf15plasmalevelsinchronicobstructivepulmonarydiseaseareassociatedwithsubclinicalcoronaryarterydisease AT wangxin gdf15plasmalevelsinchronicobstructivepulmonarydiseaseareassociatedwithsubclinicalcoronaryarterydisease AT budoffmatthewj gdf15plasmalevelsinchronicobstructivepulmonarydiseaseareassociatedwithsubclinicalcoronaryarterydisease AT dransfieldmarkt gdf15plasmalevelsinchronicobstructivepulmonarydiseaseareassociatedwithsubclinicalcoronaryarterydisease AT hokansonjohne gdf15plasmalevelsinchronicobstructivepulmonarydiseaseareassociatedwithsubclinicalcoronaryarterydisease AT kazerooniellaa gdf15plasmalevelsinchronicobstructivepulmonarydiseaseareassociatedwithsubclinicalcoronaryarterydisease AT kinneygregoryl gdf15plasmalevelsinchronicobstructivepulmonarydiseaseareassociatedwithsubclinicalcoronaryarterydisease AT reganelizabetha gdf15plasmalevelsinchronicobstructivepulmonarydiseaseareassociatedwithsubclinicalcoronaryarterydisease AT wellsjmichael gdf15plasmalevelsinchronicobstructivepulmonarydiseaseareassociatedwithsubclinicalcoronaryarterydisease AT martinezfernandoj gdf15plasmalevelsinchronicobstructivepulmonarydiseaseareassociatedwithsubclinicalcoronaryarterydisease AT hanmeilank gdf15plasmalevelsinchronicobstructivepulmonarydiseaseareassociatedwithsubclinicalcoronaryarterydisease AT curtisjeffreyl gdf15plasmalevelsinchronicobstructivepulmonarydiseaseareassociatedwithsubclinicalcoronaryarterydisease AT gdf15plasmalevelsinchronicobstructivepulmonarydiseaseareassociatedwithsubclinicalcoronaryarterydisease |